Table of Contents
Executive Summary
1 Industry Overview of Keloid Treatment
1.1 Definition of Keloid Treatment
1.2 Keloid Treatment Segment by Type
1.2.1 Global Keloid Treatment Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Occlusive Dressing
1.2.3 Compression Therapy
1.2.4 Cryosurgery
1.2.5 Excision
1.2.6 Radiation Therapy
1.2.7 Laser Therapy
1.2.8 Interferon Therapy
1.2.9 Intralesional Corticosteroid Injection
1.2.10 Others
1.3 Keloid Treatment Segment by Applications
1.3.1 Global Keloid Treatment Consumption Comparison by Applications (2014-2025)
1.3.2 Hospitals
1.3.3 Dermatology Clinics
1.3.4 Ambulatory Surgical Centres
1.3.5 Others
1.4 Global Keloid Treatment Overall Market
1.4.1 Global Keloid Treatment Revenue (2014-2025)
1.4.2 Global Keloid Treatment Production (2014-2025)
1.4.3 North America Keloid Treatment Status and Prospect (2014-2025)
1.4.4 Europe Keloid Treatment Status and Prospect (2014-2025)
1.4.5 China Keloid Treatment Status and Prospect (2014-2025)
1.4.6 Japan Keloid Treatment Status and Prospect (2014-2025)
1.4.7 Southeast Asia Keloid Treatment Status and Prospect (2014-2025)
1.4.8 India Keloid Treatment Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Keloid Treatment
2.3 Manufacturing Process Analysis of Keloid Treatment
2.4 Industry Chain Structure of Keloid Treatment
3 Development and Manufacturing Plants Analysis of Keloid Treatment
3.1 Capacity and Commercial Production Date
3.2 Global Keloid Treatment Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Keloid Treatment
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Keloid Treatment Production and Capacity Analysis
4.2 Keloid Treatment Revenue Analysis
4.3 Keloid Treatment Price Analysis
4.4 Market Concentration Degree
5 Keloid Treatment Regional Market Analysis
5.1 Keloid Treatment Production by Regions
5.1.1 Global Keloid Treatment Production by Regions
5.1.2 Global Keloid Treatment Revenue by Regions
5.2 Keloid Treatment Consumption by Regions
5.3 North America Keloid Treatment Market Analysis
5.3.1 North America Keloid Treatment Production
5.3.2 North America Keloid Treatment Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Keloid Treatment Import and Export
5.4 Europe Keloid Treatment Market Analysis
5.4.1 Europe Keloid Treatment Production
5.4.2 Europe Keloid Treatment Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Keloid Treatment Import and Export
5.5 China Keloid Treatment Market Analysis
5.5.1 China Keloid Treatment Production
5.5.2 China Keloid Treatment Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Keloid Treatment Import and Export
5.6 Japan Keloid Treatment Market Analysis
5.6.1 Japan Keloid Treatment Production
5.6.2 Japan Keloid Treatment Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Keloid Treatment Import and Export
5.7 Southeast Asia Keloid Treatment Market Analysis
5.7.1 Southeast Asia Keloid Treatment Production
5.7.2 Southeast Asia Keloid Treatment Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Keloid Treatment Import and Export
5.8 India Keloid Treatment Market Analysis
5.8.1 India Keloid Treatment Production
5.8.2 India Keloid Treatment Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Keloid Treatment Import and Export
6 Keloid Treatment Segment Market Analysis (by Type)
6.1 Global Keloid Treatment Production by Type
6.2 Global Keloid Treatment Revenue by Type
6.3 Keloid Treatment Price by Type
7 Keloid Treatment Segment Market Analysis (by Application)
7.1 Global Keloid Treatment Consumption by Application
7.2 Global Keloid Treatment Consumption Market Share by Application (2014-2019)
8 Keloid Treatment Major Manufacturers Analysis
8.1 Novartis
8.1.1 Novartis Keloid Treatment Production Sites and Area Served
8.1.2 Novartis Product Introduction, Application and Specification
8.1.3 Novartis Keloid Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Sensus
8.2.1 Sensus Keloid Treatment Production Sites and Area Served
8.2.2 Sensus Product Introduction, Application and Specification
8.2.3 Sensus Keloid Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 RXi
8.3.1 RXi Keloid Treatment Production Sites and Area Served
8.3.2 RXi Product Introduction, Application and Specification
8.3.3 RXi Keloid Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Sonoma
8.4.1 Sonoma Keloid Treatment Production Sites and Area Served
8.4.2 Sonoma Product Introduction, Application and Specification
8.4.3 Sonoma Keloid Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Perrigo
8.5.1 Perrigo Keloid Treatment Production Sites and Area Served
8.5.2 Perrigo Product Introduction, Application and Specification
8.5.3 Perrigo Keloid Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Bristol-Myers Squibb
8.6.1 Bristol-Myers Squibb Keloid Treatment Production Sites and Area Served
8.6.2 Bristol-Myers Squibb Product Introduction, Application and Specification
8.6.3 Bristol-Myers Squibb Keloid Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Pacific World
8.7.1 Pacific World Keloid Treatment Production Sites and Area Served
8.7.2 Pacific World Product Introduction, Application and Specification
8.7.3 Pacific World Keloid Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Valeant
8.8.1 Valeant Keloid Treatment Production Sites and Area Served
8.8.2 Valeant Product Introduction, Application and Specification
8.8.3 Valeant Keloid Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Revitol
8.9.1 Revitol Keloid Treatment Production Sites and Area Served
8.9.2 Revitol Product Introduction, Application and Specification
8.9.3 Revitol Keloid Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Avita
8.10.1 Avita Keloid Treatment Production Sites and Area Served
8.10.2 Avita Product Introduction, Application and Specification
8.10.3 Avita Keloid Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
9 Development Trend of Analysis of Keloid Treatment Market
9.1 Global Keloid Treatment Market Trend Analysis
9.1.1 Global Keloid Treatment Market Size (Volume and Value) Forecast 2019-2025
9.2 Keloid Treatment Regional Market Trend
9.2.1 North America Keloid Treatment Forecast 2019-2025
9.2.2 Europe Keloid Treatment Forecast 2019-2025
9.2.3 China Keloid Treatment Forecast 2019-2025
9.2.4 Japan Keloid Treatment Forecast 2019-2025
9.2.5 Southeast Asia Keloid Treatment Forecast 2019-2025
9.2.6 India Keloid Treatment Forecast 2019-2025
9.3 Keloid Treatment Market Trend (Product Type)
9.4 Keloid Treatment Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Keloid Treatment Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
【掲載企業】
Novartis、Sensus、RXi、Sonoma、Perrigo、Bristol-Myers Squibb、Pacific World、Valeant、Revitol、Avita